113 results
8-K
LSTA
Lisata Therapeutics Inc
14 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
basis, the executive compensation of the Company's named executive officers as disclosed in the Proxy Statement. The final voting results with respect
8-K
a939t0bb
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
2mgou5mfgjboh 65
2 Sep 22
Business combination disclosure
4:01pm
424B3
1lgav8ug54oxl hmzg8q
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-2.1
cfo5 dd9oa5f4t0x2hb
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
tz3z08fwa ojzasb7ga
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:20pm